GPT and coinfection: We did not find significant differences in laboratory biomarkers between patients with SARS-CoV-2 + adenovirus co-infection and patients with SARS-CoV-2 mono-infection, though patients with SARS-CoV-2 + adenovirus co-infection had a numerically greater median ALT (38.5 IU/L vs. 28.5 IU/L, p = 0.33) (Table 7).